What Adaptimmune say about themselves
“Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients”
Adaptimmune Limited
- Incorporated
- 19 December 2007 (18 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Owned by
- Accounts type
- Full
- Region
- South East
- Address
- The Innovation Centre 99 Park DriveMilton ParkAbingdonOX14 4RY
Website & contact details
- Website
Filing status
- Accounts due
- 30 September 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 2 October 2027
- Last conf. stmt
- 18 September 2026
Charges
- Total
- 6
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 5
Officers 1 active
Officer details are public data from the Companies House register.
Director · Appointed 14 November 2025
British
Born March 1980 (46)
Officer history (19 former)
15 December 2025
Resigned Rawcliffe, Adrian George as Director
14 November 2025
14 November 2025
Resigned Bertrand, William Charles as Director
1 October 2025
Appointed Bertrand, William Charles as Director
30 September 2025
Resigned Henry, Margaret as Director
30 September 2025
Resigned Henry, Margaret as Secretary
9 September 2025
Resigned Wood, Gavin as Director
31 March 2025
1 April 2020
Appointed Wood, Gavin as Director
1 September 2019
Appointed Henry, Margaret as Director
1 September 2019
12 January 2017
12 January 2017
Appointed Rawcliffe, Adrian George as Director
12 January 2017
12 January 2017
12 January 2017
12 January 2017
31 December 2016
31 December 2016
23 September 2014
23 September 2014
23 September 2014
23 September 2014
Resigned Tayton-Martin, Helen Katrina as Director
23 September 2014
23 September 2014
23 September 2014
23 September 2014
30 April 2014
Appointed Henry, Margaret as Secretary
30 April 2014
25 July 2011
25 July 2011
Appointed Tayton-Martin, Helen Katrina as Director
2 December 2008
1 December 2008
17 July 2008
17 July 2008
14 May 2008
14 May 2008
19 December 2007
19 December 2007
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 09338148
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Adaptimmune Limited This company Owns 75–100% of shares
Trucs Therapeutics Limited Owns 75–100% of shares
Filings 147
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 22 September 2026 | Confirmation statement with no updates | 18 September 2026 | ||
| 25 March 2026 | Registered office address changed | |||
| 25 March 2026 | Registered office address changed | |||
| 17 December 2025 | Termination of appointment of a director | |||
| 14 November 2025 | Appointment of a director |
Some other companies at this address
Other companies in this industry
Oxford
Cambridge
Coventry
Weybridge
Stevenage
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →